CHMX · As filed with the SEC

NEXT-ChemX balance sheet, by fiscal year

The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Balance Sheets · USD

USD	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017
ASSETS
Current Assets:
Cash and Cash Equivalents	—	—	—	—	44,619	418,229	69,167	6,496
Prepaid Expenses	—	—	—	—	2,142	6,458	14,767	6,667
Accounts Receivable	—	—	—	—	—	14,146	—	—
Other Non-Operating Current Assets	—	—	—	—	—	76,561	—	—
Cash and Cash Equivalents	62,547	2,458	28,355	10,429	—	—	—	—
Other Non-Operating Current Assets	604,368	72,925	22,169	1,600	—	—	—	—
Other Non-Operating Current Assets	38,549	64,944	—	—	—	—	—	—
Total Current Assets	705,464	140,327	50,524	12,029	46,761	—	—	13,163
Property, Plant and Equipment	7,285	12,621	17,957	21,540	—	—	—	—
Intangible Assets	2,542,185	3,150,114	3,150,114	3,150,114	—	—	—	—
Total Assets	3,254,934	3,303,062	3,218,595	3,183,683	46,761	515,394	83,934	13,163
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Other Current Liabilities	—	—	—	—	—	—	—	1,740
Accounts Payable	3,119,281	2,443,207	1,548,740	777,797	47,244	10,963	3,079	—
Total Deposits	—	—	—	—	—	507,114	—	—
Accounts Payable	—	—	—	—	—	54,106	9,717	—
Other Non-Operating Current Liabilities	—	—	—	—	—	2,873	2,909	—
Other Non-Operating Current Liabilities	—	—	11,980	—	94,030	—	—	—
Short-Term Debt	—	—	—	672,500	—	—	—	—
Convertible notes payable - related party	—	—	—	15,000	—	—	—	—
Note payable - related party	—	—	—	5,900	—	—	—	—
Other Non-Operating Current Liabilities	—	—	—	—	59,895	92,152	64,370	—
Nonrelated Party	500,000	511,980	—	—	—	—	—	—
Related Party	107,445	32,238	—	—	—	—	—	—
Short-Term Debt	—	—	926,007	—	—	—	—	—
Short-Term Debt	845,000	945,000	—	—	—	—	—	—
Total Current Liabilities	4,571,726	3,932,425	2,486,727	1,471,197	201,169	—	—	—
Non-Current Liabilities:
Long-Term Debt	—	—	—	—	—	—	—	41,709
Long-Term Debt	1,585,004	—	—	—	—	—	—	—
Total Non-Current Liabilities	1,585,004	—	—	—	—	—	—	—
Total Liabilities	6,156,730	3,932,425	2,486,727	1,471,197	201,169	667,208	80,075	43,449
Stockholders’ Equity (Deficit):
Series A Preferred Stock	20	—	—	—	—	—	—	—
Series F Preferred Stock	20	—	—	—	—	—	—	—
Total Stockholders' Equity	28,547	28,547	28,347	27,385	8,959	8,956	8,944	8,620
Additional Paid-In Capital	—	—	—	—	1,196	—	—	33,205
Additional Paid-In Capital	5,396,053	5,396,053	4,396,254	3,634,034	—	177,654	154,865	—
Subscription receivable	—	—	—	—	—	—	(2,000)	—
Retained Earnings	(8,326,436)	(6,053,963)	(3,692,732)	(1,948,933)	(164,563)	(282,575)	(142,766)	(72,111)
Accumulated Other Comprehensive Income	—	—	—	—	—	(2,609)	1,495	—
Total Stockholders’ Equity (Deficit)	(2,901,796)	(629,363)	731,868	1,712,486	(154,408)	(98,574)	20,538	—
Noncontrolling Interest	—	—	—	—	—	(53,240)	(16,678)	—
Total stockholders' equity (deficit)	—	—	—	—	(154,408)	(151,814)	3,859	(30,286)
Common Stock, Shares Authorized	—	—	—	—	—	—	—	75,000,000
Shares Issued	—	—	—	—	—	—	—	8,620,000
Shares Outstanding	—	—	—	—	—	—	—	8,620,000
Total Liabilities and Stockholders’ Equity (Deficit)	3,254,934	3,303,062	3,218,595	3,183,683	46,761	515,394	83,934	13,163

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.